DG01912 | Gold preparations |
D00992 | Gold sodium thiomalate (USP); Sodium aurothiomalate (JP18) <JP> |
D08521 | Sodium aurothiosulfate (INN) |
D00237 | Auranofin (JP18/USAN/INN) <JP/US> |
D00991 | Aurothioglucose (USP) |
D07478 | Aurotioprol |
DG00763 | Penicillamine |
D00496 | Penicillamine (JAN/USP/INN) <JP/US> |
D08330 | Penicillamine hydrochloride |
D01809 | Bucillamine (JP18/INN) <JP> |
D01146 | Iguratimod (JAN/INN) <JP> |
D00448 | Sulfasalazine (USP/INN); Salazosulfapyridine (JP18) <JP/US> |
D01395 | Actarit (JAN/INN) <JP> |
D00749 | Leflunomide (JAN/USP/INN) <JP/US> |
DG00439 | Tacrolimus |
D08556 | Tacrolimus (INN) |
D00107 | Tacrolimus (USP/INN); Tacrolimus hydrate (JP18) <JP/US> |
DG00743 | Azathioprine |
D00238 | Azathioprine (JP18/USP/INN) <JP/US> |
D03033 | Azathioprine sodium (USP) <US> |
DG00681 | Methotrexate |
D00142 | Methotrexate (JP18/USP/INN) <JP/US> |
D02115 | Methotrexate sodium <US> |
D01392 | Mizoribine (JP18/INN) <JP> |
DG02020 | JAK inhibitor |
DG00719 | Ruxolitinib |
D09959 | Ruxolitinib (USAN/INN) |
D09960 | Ruxolitinib phosphate (JAN/USAN) <JP/US> |
DG02968 | Fedratinib |
D10630 | Fedratinib (USAN/INN) |
D11296 | Fedratinib hydrochloride (USAN) <US> |
D11768 | Pacritinib (USAN/INN) <US> |
DG00742 | Tofacitinib |
D09970 | Tofacitinib (USAN) |
D09783 | Tofacitinib citrate (JAN/USAN) <JP/US> |
D10308 | Baricitinib (JAN/USAN/INN) <JP/US> |
DG02829 | Upadacitinib |
D10994 | Upadacitinib (USAN/INN) <US> |
D10995 | Upadacitinib tartrate (USAN) |
D11048 | Upadacitinib hydrate (JAN) <JP> |
DG01991 | Filgotinib |
D10871 | Filgotinib (USAN/INN) |
D10872 | Filgotinib hydrochloride (USAN) |
D11106 | Filgotinib maleate (JAN/USAN) <JP> |
DG02833 | Itacitinib |
D10944 | Itacitinib (USAN/INN) |
D10945 | Itacitinib adipate (JAN/USAN) |
DG01853 | Peficitinib |
D10653 | Peficitinib (USAN/INN) |
D10721 | Peficitinib hydrobromide (JAN/USAN) <JP> |
D11400 | Abrocitinib (JAN/USAN) <JP/US> |
D11046 | Delgocitinib (JAN/USAN) <JP> |
DG01366 | Momelotinib |
D10315 | Momelotinib (USAN/INN) |
D10358 | Momelotinib dihydrochloride (USAN) |
D10889 | Momelotinib hydrochloride hydrate (JAN) |
DG02005 | Oclacitinib |
D10141 | Oclacitinib (USAN) |
D10142 | Oclacitinib maleate (USAN) |
DG03044 | Brepocitinib |
D11537 | Brepocitinib (USAN) |
D11538 | Brepocitinib tosylate (USAN) |
DG03058 | Zotiraciclib |
D11599 | Zotiraciclib (USAN) |
D11600 | Zotiraciclib citrate (USAN) |
DG03080 | Gusacitinib |
D11676 | Gusacitinib (USAN/INN) |
D11677 | Gusacitinib hydrochloride (USAN) |
DG03114 | Deuruxolitinib |
D11866 | Deuruxolitinib (USAN) |
D11867 | Deuruxolitinib phosphate (USAN) |
DG03175 | Ivarmacitinib |
D12211 | Ivarmacitinib (USAN) |
D12212 | Ivarmacitinib sulfate (USAN) |
D10365 | Gandotinib (USAN) |
D10585 | Decernotinib (USAN/INN) |
D10728 | Solcitinib (USAN/INN) |
D11970 | Ritlecitinib tosilate (JAN) |
D12118 | Nezulcitinib (USAN) |
D03203 | Abatacept (USAN/INN); Abatacept (genetical recombination) (JAN) <JP/US> |
DG01936 | TNF inhibitor |
D00742 | Etanercept (USAN/INN); Etanercept (genetical recombination) (JAN); Etanercept (genetical recombination) [Etanercept biosimilar 1] (JAN); Etanercept (genetical recombination) [Etanercept biosimilar 2] (JAN) <JP/US> |
D02598 | Infliximab (USAN/INN); Infliximab (genetical recombination) (JAN); Infliximab (genetical recombination) [Infliximab biosimilar 1] (JAN); Infliximab (genetical recombination) [Infliximab biosimilar 2] (JAN); Infliximab (genetical recombination) [Infliximab biosimilar 3] (JAN) <JP/US> |
D07436 | Afelimomab (INN) |
D02597 | Adalimumab (USAN/INN); Adalimumab (genetical recombination) (JAN); Adalimumab (genetical recombination) [Adalimumab biosimilar 1] (JAN); Adalimumab (genetical recombination) [Adalimumab biosimilar 2] (JAN); Adalimumab (genetical recombination) [Adalimumab biosimilar 3] (JAN) <JP/US> |
D03441 | Certolizumab pegol (USAN/INN); Certolizumab pegol (genetical recombination) (JAN) <JP/US> |
D04358 | Golimumab (USAN/INN); Golimumab (genetical recombination) (JAN) <JP/US> |
DG00744 | Lenalidomide |
D04687 | Lenalidomide (JAN/USAN/INN) <US> |
D09813 | Lenalidomide hydrate (JAN) <JP> |
D04690 | Lenercept (USAN/INN) |
D05146 | Nerelimomab (USAN/INN) |
D05263 | Onercept (USAN/INN) |
D05393 | Pegsunercept (USAN) |
D09944 | Ozoralizumab (USAN); Ozoralizumab (genetical recombination) (JAN) |
D10187 | Pateclizumab (USAN) |
D10320 | Placulumab (USAN/INN) |
D02596 | Tocilizumab (USAN/INN); Tocilizumab (genetical recombination) (JAN) <JP/US> |
D10161 | Sarilumab (USAN); Sarilumab (genetical receombination) (JAN) <JP/US> |
D03684 | Denosumab (USAN); Denosumab (genetical recombination) (JAN) <JP/US> |
» expand